Capricor Therapeutics Announces $23 Million Registered Direct Offering

<p>SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced that it has entered into definitive agreements with its commercial partner, Nippon Shinyaku, Co., Ltd. and funds […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/capricor-therapeutics-announces-23-million-registered-direct-offering/">Capricor Therapeutics Announces $23 Million Registered Direct Offering</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>